Mucinex Fast-Max Dm Max Maximum Strength Liquid :
Are you searching for reliable cold and flu medicine for adults? Look no further than Mucinex DM 12hr Maximum Strength Expectorant & Cough Suppressant. Featuring a robust 400mg of guaifenesin and 20mg of dextromethorphan per dose, this top-notch chest congestion & cough medicine is here to provide effective relief from bothersome mucus and persistent cough. When the cold and flu season hits, trust Mucinex for cold and flu relief for adults. Use as directed, for Adults and Children 12 years of age and over.
- COUGH COLD AND FLU MEDICINE FOR ADULTS: Mucinex DM Max expectorant & cough suppressant packs a powerful 1..2.. punch with dextromethorphan and Guaifenesin 400mg extended release, providing you with long-lasting relief from mucus congestion and cough
- EXCESS MUCUS RELIEF: Maxium strength multi-symptom relief; Mucinex DM Max is clinically proven to last up to 4hrs and provide relief for chest congestion and make coughs more productive
- EXPECTORANTS AND DECONGESTANTS FOR ADULTS: Mucinex DM Max helps clear lungs of excess mucus and phlegm to help make every day a breath of fresh air; Say goodbye to chest congestion and cough, say hello to excess mucus relief!
- EXTENDED RELEASE GUAIFENESIN: Experience 4hr relief with Mucinex DM Max extended-release 400mg guaifenesin and 20mg dextromethorphan HBr in an easier to swallow liquid format
- TRUSTED BRAND: Mucinex is the #1 Cough & Cold Brand Doctor's Trust* and is also the #1 Pharmacist Recommended Brand†; Don't be fooled by cheap imitations get the brand that doctors trust and recommend!
- COLD MEDICINE FOR ADULTS: When you need a powerful cough and cold medicine that's formulated for adults, Mucinex DM is the name to trust; Beat cold and flu symptoms with confidence
- USAGE: Use as directed; For ages 12+ years
- *IQVIA using ProVoice Survey, December 2022 †U.S. News & World Report/Pharmacy Times 2023-2024
*Note: All pictures shown are for illustration purposes only. Actual product may vary due to product enhancement.
